Meabco

Business Services · Illinois, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

875 N Michigan Ave John Hancock Ctr Ste ...

Phone Number

(312) 239-6322

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Meabco

Meabco Inc. is a drug development company based in Chicago, IL , aiming to advance BP-C2 as a drug candidate for radioprotection/radiomitigation. Its parent company, Meabco A/S, with offices in Denmark , Russia , Norway , and the United States , focuses on breakthrough therapies in cancer treatment and radioprotection. Meabco's technology platform is based on BP-Cx-1, a patented complex of lignin-derived polyphenols, which can be conjugated with different agents to produce functionally different pharmaceuticals. BP-C1 (BP-Cx-1 complexed with platinum) is an oncology drug that has been studied in multiple Phase 1 and 2 clinical trials and is being developed for late stage cancers. BP-C2 (BP-Cx-1 complexed with molybdenum) is a preclinical stage asset that is being developed as a radioprotective and radiomitigative agent with applications in oncology and public health preparedness.Explore more
Meabco's Social MediaPopular SearchesMeabco A/SMeabco IncMebucoMeabcoMeabco A/ SSIC Code 87,873NAICS Code 54,541Show more

Meabco Org Chart

PhoneEmail
BC
United States flag for contact location.

Director, Business Development

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Meabco your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Meabco

Compare insights from companies similar to Meabco, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Meabco

<$5M
11-50
Private
-
2001
BC
Beth CuteDirector, Business Development
$5.2M
11-50
Public
$35.6M
2019
Andrew Sims, Chief Financial Officer & VP at Plus Therapeutics
Andrew SimsChief Financial Officer & VP
<$5M
11-50
Private
-
-
AW
Alfred WinklerUrologic Oncologist (GU Cancer Surgeon)
<$5M
11-50
Public
$27.2M
2009
<$5M
11-50
Public
$57.4M
2014
CL
Christopher LeonardiAlliances & Partnerships Head of Commercial
1-10
Public
$12.5M
2005
Geordan Pursglove, Chairman, President & Chief Executive Officer at Lixte
Geordan PursgloveChairman, President & CEO
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Meabco is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Meabco is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Meabco.

Meabco Tech Stack

A closer look at the technologies used by Meabco

Meabco News & Media

Read more news

Top Business Services Companies

Frequently Asked Questions Regarding Meabco

What is Meabco's official website?
Meabco's official website is www.meabco.com
What is Meabco's Revenue?
Meabco's revenue is <$5 Million
What is Meabco's SIC code?
Meabco's SIC: 87,873
What is Meabco's NAICS code?
Meabco's NAICS: 54,541
How many employees does Meabco have?
Meabco has 11-50 employees
What industry does Meabco belong to?
Meabco is in the industry of: Business Services, Research & Development
What is Meabco competition?
Meabco top competitors include: RenovoRx, Da Zen Theranostics, Lixte, Notable Labs
What technology does Meabco use?
Some of the popular technologies that Meabco uses are: WordPress.org, PHP, Google Font API, Google Global Site Tag
How do I contact Meabco?
Meabco contact info: Phone number: (312) 239-6322 Website: www.meabco.com
What does Meabco do?

Meabco Inc. is a drug development company based in Chicago, IL , aiming to advance BP-C2 as a drug candidate for radioprotection/radiomitigation. Its parent company, Meabco A/S, with offices in Denmark , Russia , Norway , and the United States , focuses on breakthrough therapies in cancer treatment and radioprotection. Meabco's technology platform... is based on BP-Cx-1, a patented complex of lignin-derived polyphenols, which can be conjugated with different agents to produce functionally different pharmaceuticals. BP-C1 (BP-Cx-1 complexed with platinum) is an oncology drug that has been studied in multiple Phase 1 and 2 clinical trials and is being developed for late stage cancers. BP-C2 (BP-Cx-1 complexed with molybdenum) is a preclinical stage asset that is being developed as a radioprotective and radiomitigative agent with applications in oncology and public health preparedness.Read More

What are Meabco social media links?
Meabco Linkedin page Meabco Twitter page Meabco Facebook page
Is Meabco a public company?
Meabco is private company therefore does not currently have an official ticker symbol
See more information about Meabco

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.